{"billNo":"202110079330000","相關附件":[{"網址":"https://ppg.ly.gov.tw/ppg/download/agenda1/02/pdf/11/02/10/LCEWA01_110210_00071.pdf","名稱":"關係文書PDF(更正版)"},{"網址":"https://ppg.ly.gov.tw/ppg/download/agenda1/02/word/11/02/10/LCEWA01_110210_00071.doc","名稱":"關係文書DOC(更正版)"}],"議案流程":[{"會期":"11-02-10","院會/委員會":"院會","狀態":"排入院會 (交財政委員會)","日期":["2024-11-22"],"會議代碼":"院會-11-2-10"},{"會期":"11-02-10","院會/委員會":"院會","狀態":"交付審查","日期":["2024-11-22"],"會議代碼":"院會-11-2-10"}],"關連議案":[],"議案名稱":"「海關進口稅則第二十一章增訂增註三草案」，請審議案。","提案單位/提案委員":"本院委員蘇清泉等29人","議案狀態":"交付審查","議案類別":"法律案","提案來源":"委員提案","屆期":11,"會期":2,"meet_id":"院會-11-2-10","laws":["01529"],"mtime":"2024-12-02T18:20:20+08:00","提案人":["蘇清泉","廖偉翔"],"字號":"院總第20號委員提案第11007933號","案由":"本院委員蘇清泉、廖偉翔等23人，有鑑於陳情，製造業藥商進口EPA Ethy1 Ester 70係原料魚油經有機化學酯化反應而成，屬製造衛部藥製字第061180號許可證「Ethyl Icosapentate \"C.C.S.B.\"」原料藥之中間體，故食藥署認為，應以藥品原料藥中間體申請進口。然而，海關卻將藥品原料藥歸屬適用稅則以現有海關進口稅則第二十一章雜項調製食品，但藥商並非食品商，衛福部食藥署認為該進口品項係做為藥品原料藥之中間體。現有規定已不合時宜，實亟需檢討修正。爰擬具「海關進口稅則第二十一章增訂增註三草案」，以作為與食品之區隔。是否有當？敬請公決。","連署人":["盧縣一","王正旭","許宇甄","高金素梅","吳宗憲","羅智強","黃仁","黃建賓","林沛祥","張智倫","丁學忠","牛煦庭","廖先翔","葛如鈞","陳菁徽","鄭正鈐","陳雪生","洪孟楷","顏寬恒","謝龍介","邱鎮軍","羅廷瑋","羅明才","楊瓊瓔","傅崐萁","翁曉玲","林思銘"],"提案編號":"20委11007933","first_time":"2024-11-22","last_time":"2024-11-22","ppg_url":"https://ppg.ly.gov.tw/ppg/bills/202110079330000/details"}